The medical dyes Omniscan, Magnevist, OptiMARK, MultiHance, and ProHance are injected into patients prior to Magnetic Resonance Imaging (MRI) and/or MRA (Angiography) scans to create a clearer image of blood flow and blood vessels. These dyes contain an agent called gadolinium, and are referred to as gadolinium-based dyes.

Exposure to gadolinium based dyes prior to MRI or MRA scans has been linked to the development of the debilitating disease Nephrogenic Systemic Fibrosis (NSF), which can be fatal. NSF is caused solely by gadolinium and gadolinium can only get into a person’s system by injection prior to a MRI with contrast or MRA medical scan.

There has been a black box alert since 2006 regarding the risk of NSF associated with MRI and MRA contrast agents containing gadolinium. The Food and Drug Administration issued further warnings in May 2007. As of December 2006, 90 cases of NSF have been reported to the FDA.

If you have developed a serious such as Nephrogenic Systemic Fibrosis after receiving an MRI or MRA, please contact an attorney at Lieff Cabraser. There is no charge or obligation for our review of your case.

Alternatively, you may contact Lieff Cabraser personal injury attorney Heather Foster at 1-800-541-7358 (the call is toll-free).